The Timing of Cancer Drug Approvals in the United States and Europe
JAMA Netw Open
.
2022 Jun 1;5(6):e2216191.
doi: 10.1001/jamanetworkopen.2022.16191.
Author
Kristina Jenei
1
Affiliation
1
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
PMID:
35687342
DOI:
10.1001/jamanetworkopen.2022.16191
No abstract available
Publication types
Comment
MeSH terms
Drug Approval*
Europe
Humans
Neoplasms* / drug therapy
United States
United States Food and Drug Administration